We chose HeLa cells due to their low baseline PI3K/AKT signaling (Appendix Fig. S1F), absence of pathway-specific mutations, in-depth characterization at multiple biological levels (transcriptomics, proteomics (Bekker-Jensen et al, 2017)), experimental tractability and, in particular, their cervical cancer origin. Here, PIK3CA is linked to cervical cancer.